|
|
|
| Curative Effect of Parecoxib Sodium Combined with Dexmedetomidine on the Blood Glucose Insulin Cortisol and Stress Response of Patients underwent Thoracic Surgery |
| Guliparikelimu, ZHANG Lei, ZHU Sujie, et al |
| The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Urumqi 830054, China |
|
|
|
|
Abstract Objective: To study the curative effect of parecoxib sodium combined with dexmedetomidine on the blood glucose, insulin, cortisol and stress response of patients underwent thoracic surgery. Methods: 80 patients of thoracic surgery who were treated from April 2014 to April 2015 in our hospital were selected as research objects. According to the draw method, these patients were divided into the observation group and the control group, 40 cases in each group. The control group was treated with 40mg parecoxib sodium through intravenous injection at half an hour before operation, while the observation group was treated with slow injection of dexmedetomidine 0.5μg/kg at 5 minutes before the end of operation. The intraoperative hemorrhage and blood transfusion volume, recovery time of breath, waking time, extubation time, the changes of blood glucose, insulin, cortisol, epinephrine and norepinephrine, mean artery pressure (MAP), heart rate (HR), respiration rate (RR), visual analogue scale/score (VAS), ramsay score before induction (T1), at the end of operation (T2) and immediately after extubation were compared between two groups. Results: There was no significant difference in the intraoperative blood loss, intraoperative blood transfusion, recovery time, recovery time of breath and extubation time between the two groups (P>0.05); the blood glucose, insulin and cortisol levels in the observation group at T1, T2 were significantly lower than those of the control group [(5.04±0.74)mmol/L vs (6.83±0.75)mmol/L, (6.73±0.61)mmol/L vs (7.69±0.83)mmol/L, (15.59±1.89)μIU/mL vs (20.86±2.03)μIU/mL, (14.93±1.82)μIU/mL vs (17.53±1.94)μIU/mL, (370.26±62.07)nmol/L vs (560.49±70.53)nmol/L, (402.86±63.75)nmol/L vs (694.27±78.36)nmol/L](P<0.05); the epinephrine and norepinephrine levels at T1, T2 were significantly lower than those of the control group [(48.28±16.20)ng/mL vs (79.36±18.37)ng/mL, (77.39±18.20)ng/mL vs (96.38±19.75)ng/mL, (316.25±43.55)ng/mL vs (402.17±53.47)ng/mL, (398.46±54.32)ng/mL vs (475.62±56.29)ng/mL] (P<0.05); the MAP, HR at T1, T2 were significantly lower than those of the control group [(77.34±6.19)mmHg vs (84.59±6.12)mmHg, (76.40±5.89)mmHg vs (81.49±5.97)mmHg, (89.80±9.46)time /min vs (95.70±9.80)time /min, (87.57±8.09) time/min vs (94.45±8.90) time/min] (P<0.05); VAS, Ramsay scores were significantly lower than those of control group [(2.56±0.35)score vs (5.30±0.78)score, (3.63±0.90) score vs (6.42±1.08) score] (P<0.05). Conclusion: Parecoxib sodium and dexmedetomidine had a synergic role, it could reduce the blood glucose, insulin, cortisol, relieve the pain, relieve restlessness, but wouldn't cause greater stress response and was conducive to the prognosis of patients.
|
|
|
|
|
|
[1] 潘尉洲,李艳华,薄云,等.帕瑞昔布钠联合地佐辛预防开胸手术患者全麻苏醒期躁动的临床研究[J].中国临床药理学杂志,2013,29(12):903~905.
[2] 吕东海,靳红绪,史双友,等.帕瑞昔布钠联合右美托咪定对开胸手术患者麻醉恢复期躁动的影响[J].中国现代医学杂志,2016,26(20):126~129.
[3] 邱爽,董有静,段丽芳.帕瑞昔布钠超前镇痛联合舒芬太尼术后镇痛对老年患者术后早期认知功能的影响[J].实用药物与临床,2016,19(04):425~429.
[4] 李明月,刘伟,赖冰洁,等.老年患者开胸手术术后镇痛的研究进展[J].中国老年学杂志,2016,36(06):1522~1524.
[5] 陈涛,黄觉儒,郑传东.开胸手术患者采用硬膜外辅助全身麻醉对血流动力学及血气的影响[J].湖南师范大学学报(医学版),2017,14(03):82~85.
[6] 周兴根.不同麻醉和术后镇痛方式对中老年胸科手术后胰岛素抵抗的影响[J].中国老年学杂志,2014,34(02):521~522.
[7] 苏玉强,郑仲磊,李静,等.诱导前帕瑞昔布钠干预对腹腔镜手术后炎症应激反应、内分泌稳态的影响[J].海南医学院学报,2017,23(12):1640~1643.
[8] 赵一璠,郝建华,苏小军,等.地佐辛复合右美托咪定在开胸术后镇痛的应用效果[J].新乡医学院学报,2014,31(04):296~298.
[9] 徐西通.右美托咪定及地佐辛或右美托咪定联合地佐辛对开胸术患者麻醉恢复期躁动的影响[J].河北医学,2014,20(12):1979~1983.
[10] 彭蓓,郑利民,罗涛,等.帕瑞昔布钠联合右美托咪定对开胸手术患者苏醒质量及应激反应的影响[J].现代生物医学进展,2017,17(20):3860~3863. |
|
|
|
2018, Vol. 24 
